| Dr Sheldon J Black, MD | |
|
833 Saint Vincents Dr, Pob# 3 Suite 402, Birmingham, AL 35205-1606 | |
| (205) 933-9236 | |
| (205) 933-9213 |
| Full Name | Dr Sheldon J Black |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 36 Years |
| Location | 833 Saint Vincents Dr, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922012699 | NPI | - | NPPES |
| 000022986 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 18338 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Vincent's Birmingham | Birmingham, AL | Hospital |
| Cullman Regional Medical Center | Cullman, AL | Hospital |
| Grandview Medical Center | Birmingham, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ent Associates Of Alabama, P.c. | 8921025354 | 34 |
News Archive
More than 50 million Americans will experience some degree of tinnitus in their lifetime, according to the American Tinnitus Association. Tinnitus is a hearing condition that causes the constant misperception of sound, including hissing, ringing and rushing noises. A study recently published in Panminerva Medica reveals that Pycnogenol (pic-noj-en-all), an antioxidant plant extract derived from the bark of the French maritime pine tree, is effective in relieving tinnitus symptoms by improving blood flow in the inner ear.
Regulus Therapeutics Inc. announced today that the United States Patent and Trademark Office (USPTO) has allowed claims in U.S. Application Serial No. 11/977,506 covering methods of antagonizing miR-181a to regulate immune response. This patent is owned by Stanford University and licensed exclusively to Regulus. miR-181a has been shown to regulate the response of immune cells, such as T lymphocytes, to specific stimuli and modulation of miR-181a could lead to a novel treatment of inflammatory disease.
In a two-year evaluation at Group Health Cooperative, transforming primary care into a "patient-centered medical home" model paid off.
Baxter International Inc. today announced plans to create two separate, independent global healthcare companies - one focused on developing and marketing innovative biopharmaceuticals and the other on life-saving medical products. Both will be global leaders in their respective markets.
› Verified 1 days ago
| Entity Name | Ent Associates Of Alabama, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841301082 PECOS PAC ID: 8921025354 Enrollment ID: O20051025001005 |
News Archive
More than 50 million Americans will experience some degree of tinnitus in their lifetime, according to the American Tinnitus Association. Tinnitus is a hearing condition that causes the constant misperception of sound, including hissing, ringing and rushing noises. A study recently published in Panminerva Medica reveals that Pycnogenol (pic-noj-en-all), an antioxidant plant extract derived from the bark of the French maritime pine tree, is effective in relieving tinnitus symptoms by improving blood flow in the inner ear.
Regulus Therapeutics Inc. announced today that the United States Patent and Trademark Office (USPTO) has allowed claims in U.S. Application Serial No. 11/977,506 covering methods of antagonizing miR-181a to regulate immune response. This patent is owned by Stanford University and licensed exclusively to Regulus. miR-181a has been shown to regulate the response of immune cells, such as T lymphocytes, to specific stimuli and modulation of miR-181a could lead to a novel treatment of inflammatory disease.
In a two-year evaluation at Group Health Cooperative, transforming primary care into a "patient-centered medical home" model paid off.
Baxter International Inc. today announced plans to create two separate, independent global healthcare companies - one focused on developing and marketing innovative biopharmaceuticals and the other on life-saving medical products. Both will be global leaders in their respective markets.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sheldon J Black, MD 833 Saint Vincents Dr, Pob# 3 Suite 402, Birmingham, AL 35205-1606 Ph: (205) 933-9236 | Dr Sheldon J Black, MD 833 Saint Vincents Dr, Pob# 3 Suite 402, Birmingham, AL 35205-1606 Ph: (205) 933-9236 |
News Archive
More than 50 million Americans will experience some degree of tinnitus in their lifetime, according to the American Tinnitus Association. Tinnitus is a hearing condition that causes the constant misperception of sound, including hissing, ringing and rushing noises. A study recently published in Panminerva Medica reveals that Pycnogenol (pic-noj-en-all), an antioxidant plant extract derived from the bark of the French maritime pine tree, is effective in relieving tinnitus symptoms by improving blood flow in the inner ear.
Regulus Therapeutics Inc. announced today that the United States Patent and Trademark Office (USPTO) has allowed claims in U.S. Application Serial No. 11/977,506 covering methods of antagonizing miR-181a to regulate immune response. This patent is owned by Stanford University and licensed exclusively to Regulus. miR-181a has been shown to regulate the response of immune cells, such as T lymphocytes, to specific stimuli and modulation of miR-181a could lead to a novel treatment of inflammatory disease.
In a two-year evaluation at Group Health Cooperative, transforming primary care into a "patient-centered medical home" model paid off.
Baxter International Inc. today announced plans to create two separate, independent global healthcare companies - one focused on developing and marketing innovative biopharmaceuticals and the other on life-saving medical products. Both will be global leaders in their respective markets.
› Verified 1 days ago
Dr. Grayson K Rodgers, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2700 10th Ave S Ste 502, Birmingham, AL 35205 Phone: 205-933-2951 Fax: 205-933-5893 | |
Dr. Jessica Warren Grayson, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 | |
Brian Kulbersh, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1940 Elmer J Bissell Rd, Birmingham, AL 35243 Phone: 205-638-4949 Fax: 205-638-4982 | |
Dr. Richard Kailean Mchugh, MD, PHD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, The Kirklin Clinic, Birmingham, AL 35233 Phone: 205-801-8000 | |
Paul F Castellanos, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Dr. David Michael Walters, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1809 Gadsden Hwy, Birmingham, AL 35235 Phone: 205-838-3755 Fax: 205-838-3755 | |
Do Yeon Cho, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-934-9999 |